What are the current pneumococcal vaccination guidelines for adults (including those ≥65 years, 19‑64 years with chronic medical conditions, and immunocompromised patients) and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 22, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

Which patient factors—age, comorbidities, immune status, and prior pneumococcal vaccination—should guide my choice between PCV20, PCV15, and PPSV23?

What is the Pneumococcal (PCV) 20 vaccination guideline for high-risk individuals, including adults aged 65 and older or those with immunocompromising conditions such as chronic heart disease, lung disease, or diabetes?

What are the recommendations for administering the Pneumococcal Conjugate Vaccine 20 (PCV 20) to adults, particularly those 65 years or older or with underlying medical conditions such as chronic heart disease, chronic lung disease, or immunocompromising conditions?

What is the recommended dosing and administration schedule for Pneumococcal Conjugate Vaccine 20 (PCV20)?

What is the recommended prescribing guideline for Pneumococcal Conjugate Vaccine (PCV) 20?

In a hemodynamically stable adult, at what hemoglobin (or hematocrit) level should a blood transfusion be given, and how do the thresholds change for patients with coronary artery disease, heart failure, cerebrovascular disease, undergoing major surgery, or in third‑trimester pregnancy?

What is the appropriate evaluation and management of a patient with elevated troponin after a blood transfusion?

What is the recommended multidisciplinary postoperative management for a patient after a below‑knee amputation?

What are the clinical presentation, diagnostic work‑up, and management recommendations for Fragile X syndrome?

How should I evaluate and manage pelvic vascular congestion (pelvic congestion syndrome) in a reproductive‑age woman with chronic pelvic pain that worsens with prolonged standing, sexual activity, or during the luteal phase, and no identifiable uterine, ovarian, or gastrointestinal pathology?

What are the primary symptoms of pelvic congestion syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.